{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:30:24Z","timestamp":1761823824475,"version":"3.37.3"},"reference-count":74,"publisher":"American Society for Microbiology","issue":"22","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["FP7 project 602604"],"award-info":[{"award-number":["FP7 project 602604"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2016,11,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Due to antigenic drift of influenza viruses, seasonal influenza vaccines need to be updated annually. These vaccines are based on predictions of strains likely to circulate in the next season. However, vaccine efficacy is greatly reduced in the case of a mismatch between circulating and vaccine strains. Furthermore, novel antigenically distinct influenza viruses are introduced into the human population from animal reservoirs occasionally and may cause pandemic outbreaks. To dampen the impact of seasonal and pandemic influenza, vaccines that induce broadly protective and long-lasting immunity are preferred. Because influenza virus-specific CD8<jats:sup>+<\/jats:sup>T cells are directed mainly against relatively conserved internal proteins, like nucleoprotein (NP), they are highly cross-reactive and afford protection against infection with antigenically distinct influenza virus strains, so-called heterosubtypic immunity. Here, we used modified vaccinia virus Ankara (MVA) as a vaccine vector for the induction of influenza virus NP-specific CD8<jats:sup>+<\/jats:sup>T cells. To optimize the induction of CD8<jats:sup>+<\/jats:sup>T cell responses, we made several modifications to NP, aiming at retaining the protein in the cytosol or targeting it to the proteasome. We hypothesized that these strategies would increase antigen processing and presentation and thus improve the induction of CD8<jats:sup>+<\/jats:sup>T cell responses. We showed that NP with increased degradation rates improved CD8<jats:sup>+<\/jats:sup>T cell activation<jats:italic>in vitro<\/jats:italic>if the amount of antigen was limited or if CD8<jats:sup>+<\/jats:sup>T cells were of low functional avidity. However, after immunization of C57BL\/6 mice, no differences were detected between modified NP and wild-type NP (NPwt), since NPwt already induced optimal CD8<jats:sup>+<\/jats:sup>T cell responses.<\/jats:p><jats:p><jats:bold>IMPORTANCE<\/jats:bold>Due to the continuous antigenic drift of seasonal influenza viruses and the threat of a novel pandemic, there is a great need for the development of novel influenza vaccines that offer broadly protective immunity against multiple subtypes. CD8<jats:sup>+<\/jats:sup>T cells can provide immunity against multiple subtypes of influenza viruses by the recognition of relatively conserved internal antigens. In this study, we aimed at optimizing the CD8<jats:sup>+<\/jats:sup>T cell response to influenza A virus by making modifications to influenza A virus nucleoprotein (NP) expressed from the modified vaccinia virus Ankara (MVA) vaccine vector. These modifications resulted in increased antigen degradation, thereby producing elevated levels of peptides that can be presented on major histocompatibility complex (MHC) class I molecules to CD8<jats:sup>+<\/jats:sup>T cells. Although we were unable to increase the NP-specific immune response in the mouse strain used, this approach may have benefits for vaccine development using less-immunogenic proteins.<\/jats:p>","DOI":"10.1128\/jvi.01633-16","type":"journal-article","created":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:21:41Z","timestamp":1472689301000},"page":"10209-10219","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":7,"title":["Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8<sup>+<\/sup>T Cell Activation<i>In Vitro<\/i>but Not in C57BL\/6 Mice"],"prefix":"10.1128","volume":"90","author":[{"given":"Arwen F.","family":"Altenburg","sequence":"first","affiliation":[{"name":"Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolien E.","family":"van de Sandt","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella E.","family":"van Trierum","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi L. M.","family":"De Gruyter","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R. W. A.","family":"van Run","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron A. M.","family":"Fouchier","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenny","family":"Roose","sequence":"additional","affiliation":[{"name":"Medical Biotechnology Center, VIB, Ghent, Belgium"},{"name":"Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Saelens","sequence":"additional","affiliation":[{"name":"Medical Biotechnology Center, VIB, Ghent, Belgium"},{"name":"Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asisa","family":"Volz","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases and Zoonoses, LMU University of Munich, Munich, Germany"},{"name":"German Centre for Infection Research (DZIF), Braunschweig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Sutter","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases and Zoonoses, LMU University of Munich, Munich, Germany"},{"name":"German Centre for Infection Research (DZIF), Braunschweig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory D.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guus F.","family":"Rimmelzwaan","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands"},{"name":"ViroClinics Biosciences BV, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1244730"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.043059-0"},{"key":"e_1_3_1_4_2","first-page":"1186","volume-title":"Fields virology","author":"Wright PF","year":"2013","unstructured":"Wright PF, Neumann G, Kawaoka Y. 2013. Orthomyxoviruses, p 1186\u20131243. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.","edition":"6"},{"key":"e_1_3_1_5_2","first-page":"1151","volume-title":"Fields virology","author":"Shaw ML","year":"2013","unstructured":"Shaw ML, Palese P. 2013. Orthomyxoviridae, p 1151\u20131185. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.","edition":"6"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41902"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.5.2552-2558.1993"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003942"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1171491"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03509-12"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1414070111"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.11.054"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2003.01738.x"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(84)90187-9"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.6.1785"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.11.8682-8689.1998"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32460"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198307073090103"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.4049\/jimmunol.162.12.7578","article-title":"Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species","volume":"162","author":"Jameson J","year":"1999","unstructured":"Jameson J, Cruz J, Terajima M, Ennis FA. 1999. Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol 162:7578\u20137583.","journal-title":"J Immunol"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.033076-0"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.08.036"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.079"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00519-10"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3350"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02843-13"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01460-06"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00397-07"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","unstructured":"Skowronski DM Chambers C Sabaiduc S De Serres G Dickinson JA Winter AL Drews SJ Fonseca K Charest H Gubbay JB Petric M Krajden M Kwindt TL Martineau C Eshaghi A Bastien N Li Y. 2015. Interim estimates of 2014\/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network January 2015. Euro Surveill 20(4):pii=21022. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=21022.","DOI":"10.2807\/1560-7917.ES2015.20.4.21022"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","unstructured":"Pebody RG Warburton F Ellis J Andrews N Thompson C von Wissmann B Green HK Cottrell S Johnston J de Lusignan S Moore C Gunson R Robertson C McMenamin J Zambon M. 2015. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014\/15 mid-season results. Euro Surveill 20(5):pii=21025. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=21025.","DOI":"10.2807\/1560-7917.ES2015.20.5.21025"},{"key":"e_1_3_1_30_2","first-page":"10","article-title":"Early estimates of seasonal influenza vaccine effectiveness\u2014United States, January 2015","volume":"64","author":"Flannery B","year":"2015","unstructured":"Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, Gaglani M, Berman L, Foust A, Sessions W, Thaker SN, Spencer S, Fry AM, Centers for Disease Control and Prevention. 2015. Early estimates of seasonal influenza vaccine effectiveness\u2014United States, January 2015. MMWR Morb Mortal Wkly Rep 64:10\u201315.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c7297"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1878CP"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90341-7"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.038"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.9.6418-6424.1996"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep01443"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.047"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242922"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088340"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq015"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis327"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048322"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.3390\/v6072735"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70963-6"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00075-5"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3367"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.168.4.1211"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2005.00263.x"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01434-06"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05080.x"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4049\/jimmunol.155.8.3750","article-title":"Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation","volume":"155","author":"Grant EP","year":"1995","unstructured":"Grant EP, Michalek MT, Goldberg AL, Rock KL. 1995. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J Immunol 155:3750\u20133758.","journal-title":"J Immunol"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.5.909"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00406-6"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205547200"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00903-07"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00694-12"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00310-8"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(98)00071-8"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1086\/517614"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02439-15"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1177\/0300985811429812"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(81)90482-7"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-65-6-1127"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-007-0003-8"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(03)00265-5"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00009-06"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.11.8497-8503.1997"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00134-0"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.05.035"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80573-7"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1232449100"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2010.09.008"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.04.002"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.4.2126"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2012.06.002"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01633-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01633-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T22:35:06Z","timestamp":1692484506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01633-16"}},"subtitle":[],"editor":[{"given":"S.","family":"Schultz-Cherry","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":74,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016,11,15]]}},"alternative-id":["10.1128\/JVI.01633-16"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01633-16","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"type":"print","value":"0022-538X"},{"type":"electronic","value":"1098-5514"}],"subject":[],"published":{"date-parts":[[2016,11,15]]},"assertion":[{"value":"2016-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-10-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}